海尔生物(688139.SH)：前三季度净利润1.98亿元，同比下降35.83%

Core Insights - Haier Biomedical (688139.SH) reported a total revenue of 1.761 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 1.17% [1] - The net profit attributable to shareholders of the parent company was 198 million yuan, down 35.83% year-on-year [1] - The basic earnings per share stood at 0.63 yuan [1]